HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List for ELUNATE® and ORPATHYS® | HCM Stock NewsStockTitan·Nov 15, 2026 at 08:00 PMHCM-1.90%HAWG-0.78%
Weekly Recap | HUTCHMED -3.24%, most brokers rate it buyWeekly Review·Nov 14, 2026 at 05:05 AM00013-2.08%
UK Stock Market Today: FTSE 100 Futures Dip As Housing Weakness Clouds GDP OutlookSimplywall·Nov 9, 2026 at 07:23 AMHCM-1.90%HAWG-0.78%
Weekly Recap | HUTCHMED +11.78%, two regulatory updates spark gainsWeekly Review·Nov 7, 2026 at 05:26 AM00013-2.08%
Citi Hikes HUTCHMED TP to HKD43.2, Lifts Revenue and EPS Forecasts, Names It New Top PickAASTOCKS News·Nov 6, 2026 at 03:53 AMHCM-1.90%HAWG-0.78%
NIOX Group And 2 Other British Healthcare Stocks To OwnSimplywall·Nov 5, 2026 at 11:08 AMAZN-1.01%HCM-1.90%
HUTCHMED climbs 6% as sovleplenib wins FDA orphan drug statusMarket Movers·Nov 5, 2026 at 02:30 AM00013-2.08%
HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia | HCM Stock NewsStockTitan·Nov 4, 2026 at 04:00 PMHCM-1.90%HAWG-0.78%
Regulatory filings for lung cancer therapy advancePharmaTimes·Nov 2, 2026 at 12:18 PMAZN-1.01%HCM-1.90%
Citi: China Pharma and Biotech ESMO Data Further Validated; Favors CSPC PHARMA , HENGRUI PHARMA , INNOVENT BIO and SKB BIOAASTOCKS News·Nov 2, 2026 at 10:30 AM01093-2.59%01276-2.66%
HUTCHMED (China) Limited EMA, Japan Accept Reviews for Savolitinib + OsimertinibTradingView·Nov 2, 2026 at 12:00 AMHCM-1.90%HAWG-0.78%
HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan | HCM Stock NewsStockTitan·Nov 1, 2026 at 04:00 PMAZN-1.01%HCM-1.90%
Hutchmed reports phase 3 SANOVO data for first‑line lung cancerPharmaTimes·Oct 29, 2026 at 09:57 AMHCM-1.90%HAWG-0.78%
HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia | HCM Stock NewsStockTitan·Oct 28, 2026 at 04:00 PMHCM-1.90%HAWG-0.78%
Chinese Cancer Drugmakers Raise Global Stakes With Record Oncology Congress ShowingYicai·Oct 28, 2026 at 11:53 AMHCM-1.90%HAWG-0.78%